EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of RNA Aptamers That Inhibit the RNA-Dependent RNA Polymerase Activity of SARS-CoV-2 Strains In Vitro

Chaewon Song, Seong-Wook Lee iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chaewon Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioconvergence Engineering, Research Institute of Advanced Omics, Dankook University, Yongin 16890, Republic of Korea. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, SARS-CoV-2, RNA-Dependent RNA Polymerase, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continuous emergence of SARS-CoV-2 variants with enhanced transmissibility and immune escape capability underscores the urgent need for mutation-independent anti-viral strategies. SARS-CoV-2 non-structural protein 12 (NSP12), which encodes the RNA-dependent RNA polymerase (RdRp), is an essential component of the viral replication complex and represents a highly conserved target for therapeutic intervention. In this study, we developed RNA aptamers, composed of 2′-hydroxyl nucleotides or 2′-fluoro pyrimidines, targeting NSP12 using the SELEX (Systematic Evolution of Ligands by EXponential enrichment) approach. SELEX was performed with purified NSP12 protein derived from the Omicron variant, leading to the identification of aptamer candidates with high binding ability. RNA–protein pull-down assays confirmed binding between representative aptamers and NSP12 with high affinity. Competition assays supported binding specificity between aptamers and NSP12. Of note, functional evaluation using a primer extension assay revealed that the aptamers effectively inhibited NSP12 RdRp activity in vitro. Furthermore, the aptamers consistently bound to and inhibited NSP12 variants from wild-type, Alpha, Delta, and Omicron strains. These results suggest that the selected RNA aptamers are potential as broad-spectrum inhibitors targeting a conserved region of NSP12 and may serve as a promising platform for the development of anti-viral agents against current and emerging SARS-CoV-2 variants, as well as other RNA viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideSARS-CoV-2RNA-Dependent RNA PolymeraseAntiviral AgentsViral Nonstructural ProteinsSELEX Aptamer TechniqueHumansCOVID-19Coronavirus RNA-Dependent RNA PolymeraseVirus ReplicationProtein Binding

Stichwörter der Autor:innen

NSP12RNA aptamerRNA-dependent RNA polymeraseSARS-CoV-2

Substanzen

Aptamers, NucleotideRNA-Dependent RNA PolymeraseNSP12 protein, SARS-CoV-2Antiviral AgentsViral Nonstructural ProteinsCoronavirus RNA-Dependent RNA Polymerase

Autor:innen und Institutionen

  • Department of Bioconvergence Engineering, Research Institute of Advanced Omics, Dankook University, Yongin 16890, Republic of Korea.
  • R&D Center, Rznomics Inc., Seongnam 13486, Republic of Korea.

ORCID-Profile: Seong-Wook Lee

Zitieren

APA

Song, C., & Lee, S. W. (2025). Development of RNA Aptamers That Inhibit the RNA-Dependent RNA Polymerase Activity of SARS-CoV-2 Strains In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211177

Vancouver

Song C, Lee SW. Development of RNA Aptamers That Inhibit the RNA-Dependent RNA Polymerase Activity of SARS-CoV-2 Strains In Vitro. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211177

BibTeX
@article{Song2025,
  author = {Song, Chaewon and Lee, Seong-Wook},
  title = {Development of RNA Aptamers That Inhibit the RNA-Dependent RNA Polymerase Activity of SARS-CoV-2 Strains In Vitro},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211177}
}
Kostenlos starten →